Kazia Therapeutics (KZIA) Depreciation & Amortization (CF) (2009 - 2022)
Kazia Therapeutics (KZIA) posted Depreciation & Amortization (CF) of $614145.2 for Q4 2022, down 9.81% on a QoQ basis from $680937.6 in Q4 2021, and down 9.81% year-over-year from $680937.6 in Q4 2021.
Kazia Therapeutics (KZIA) Depreciation & Amortization (CF) (2009 - 2022) Analysis & Trends
Kazia Therapeutics' Depreciation & Amortization (CF) history runs 5 years deep, the most recent figure standing at $614145.2 for Q4 2022.
- Quarterly Depreciation & Amortization (CF) fell 9.81% year-over-year to $614145.2 in Q4 2022, while the trailing twelve-month figure through Jun 2024 was $614145.2 (down 52.58% YoY) and the FY2017 annual result came in at $1.1 million, up 128.5% from the prior year.
- Depreciation & Amortization (CF) was $614145.2 for Q4 2022 at Kazia Therapeutics, down from $680937.6 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $680937.6 in Q4 2021 and bottomed at $396292.4 in Q4 2020.
- A 3-year average of $563791.7 and a median of $614145.2 in 2022 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2021 — Depreciation & Amortization (CF) surged 71.83% — and 2022, when it retreated 9.81%.
- Kazia Therapeutics' Depreciation & Amortization (CF) stood at $396292.4 in 2020, then surged by 71.83% to $680937.6 in 2021, then slipped by 9.81% to $614145.2 in 2022.
- Business Quant data shows KZIA's Depreciation & Amortization (CF) at $614145.2 in Q4 2022, $680937.6 in Q4 2021, and $396292.4 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 196,658.72 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 41.14 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 91,781.47 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 55.90 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 123.20 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.20 Mn |
| 10 | Kazia Therapeutics | 4.11 Mn | 4.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 614,145.22 |
| Dec 31, 2022 | 614,145.22 |
| Dec 31, 2021 | 680,937.65 |
| Dec 31, 2021 | 680,937.65 |
| Dec 31, 2020 | 396,292.37 |
| Dec 31, 2020 | 396,292.37 |
| Dec 31, 2016 | 415,677.77 |
| Dec 31, 2016 | 415,677.77 |
| Dec 31, 2009 | -110,000.00 |
| Dec 31, 2009 | -110,000.00 |